Advances in the Obesity Market
This
report reviews the current state of the obesity market for both pharmaceuticals
and medical devices, examining why the obesity market is of such importance
across established and emerging economies and how current interventions measure
up.
To
Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/advances-in-the-obesity-market
In
July 2011, the American Association of Clinical Endocrinologists (AACE)
reclassified obesity as a diseased state, not a condition, in order to move it
up the US healthcare agenda. In 2012, the FDA reviewed its stance on
anti-obesity products and approved two new products that were previously
declined.
As
it stands, there are over 40 medicines currently approved or used off label to
treat obesity, in addition there are more than 20 innovative products in
clinical development. This new report examines the latest products and devices
in development and compares them to those currently available, gathering
opinions from key industry leaders to highlight the fast-moving changes that
are affecting this profit potential market.
This
report provides you with a detailed analysis and key opinions on the current
and future obesity market...
- Detailed review of the current obesity market, answering ‘Where are we now?’ for both established and emerging economies
- Comprehensive insight into newly approved pharmaceuticals and medical devices, analysing how they compare to established brands
- Assessment of key products and devices in development, identifying ‘Ones to Watch’ in late-stage clinical development
- Reviews of products and devices that are ‘Waiting in the Wings’ in early-stage clinical development where PoC data is being gathered
- Analyses of potential ‘Long Shots’ representing new and innovative products where the rationale has yet to be fully tested.
This
report provides a comprehensive overview of existing anti-obesity therapies and
surgical interventions. It provides a systematic appraisal of each market
segment highlighting both the leading players and new entrants. The report
includes thoughts from key opinion leaders across the globe to find out where
the key challenges and opportunities exist for both pharma and medical device
manufacturers.
Table
of Contents
SCOPE
OF THE REPORT.1
CATALYST.2
About
the Author .3
SECTION
1: WHY IS OBESITY IMPORTANT, WHY NOW?.4
Introduction
–where are we now?.4
Obesity
has infiltrated every continent in the world.4
More
than 40 million children are overweight.4
Obesity
rates have doubled, if not tripled during the last 25 years .6
Brazil’s
Ministry of Health published new guidelines on the prevention and treatment of
obesity 6
Childhood
obesity is even more common in Russia than in the States .6
Indians
at higher risk of cardio-metabolic disease at lower BMI than Caucasians .6
A
fifth of China’s children are overweight.7
Obesity
is the greatest challenge to health this century .7
Reclassification
of obesity will stimulate demand.7
Reimbursement
has stifled growth but US health insurers will have to rethink medical polices
8
Reclassification
to stimulate pharma investment.8
For
More Information Pharmaceutical Market
Research Reports @:
Current
pharmacolo gical inter ventions .9
Anti-obesity
drugs have been plagued by safety issues.10
New
developments spark hope. 11
Has
Xenical lived up to market expectations?. 11
When
will generic orilstat enter the scene?. 11
How
does Xenical stack up against Belviq?. 12
How
does Qsymia stack up against Belviq?. 12
Anti
-obesity - Mar ket forecasts .14
New
drugs on the bloc k.15
Approach
1: Anorexi genic pepti de analo gues an d mo dulators .16
Drug
type 1: GLP-1 analogues and agonists.16
Ones
to watch .17
Liraglutide
(Novo Nordisk).17
Waitin
g in the win gs.18
Exenatide
(Bristol-Myers Squibb/Eli Lilly).18
About
Us
Marketresearchreports.biz
is the most comprehensive collection of market research reports.
Marketresearchreports.biz services are especially designed to save time and
money of our clients. We are a one stop solution for all your research needs,
our main offerings are syndicated research reports, custom research,
subscription access and consulting services. We serve all sizes and types of
companies spanning across various industries.
With a team of
experienced consultants we are committed to serve our clients in a way which
increase their efficiency, reduce costs and saves time. Our professional search
engine helps you in finding the best and latest market research report with
just one click of the mouse. Our database represents the most updates and
latest market research report collections form all the leading market research
publishers across the globe
Contact
M/s Sheela
90 Sate Street, Suite
700
Albany, NY 12207
USA – Canada Toll
Free: 866-997-4948
No comments:
Post a Comment